Combined delivery of a TGF-β inhibitor and an adenoviral vector expressing interleukin-12 potentiates cancer immunotherapy | |
Jiang, J.; Zhang, Y.; Peng, K.; Wang, Q.; Hong, X.; Li, H.; Fan, G.; Zhang, Z.; Gong, T.; Sun, X. | |
刊名 | Acta Biomaterialia
![]() |
2017 | |
卷号 | Vol.61页码:114-123 |
关键词 | Adenovirus Cancer immunotherapy Interleukin-12 Melanoma Transforming growth factor-β β-Cyclodextrin-PEI |
ISSN号 | 1742-7061 |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/1822104 |
专题 | 四川大学 |
作者单位 | Key Laboratory of Drug Targeting and Drug Delivery Systems, Ministry of Education, West China School of Pharmacy, Sichuan University, Chengdu, China |
推荐引用方式 GB/T 7714 | Jiang, J.,Zhang, Y.,Peng, K.,et al. Combined delivery of a TGF-β inhibitor and an adenoviral vector expressing interleukin-12 potentiates cancer immunotherapy[J]. Acta Biomaterialia,2017,Vol.61:114-123. |
APA | Jiang, J..,Zhang, Y..,Peng, K..,Wang, Q..,Hong, X..,...&Sun, X..(2017).Combined delivery of a TGF-β inhibitor and an adenoviral vector expressing interleukin-12 potentiates cancer immunotherapy.Acta Biomaterialia,Vol.61,114-123. |
MLA | Jiang, J.,et al."Combined delivery of a TGF-β inhibitor and an adenoviral vector expressing interleukin-12 potentiates cancer immunotherapy".Acta Biomaterialia Vol.61(2017):114-123. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论